LAS VEGAS, June 16, 2014 /PRNewswire/ -- GrowBLOX Sciences,
Inc. (OTCQB: GBLX) a biotechnology and research company, today
announced that The Company has named its Chief Science Officer and
Member of the Board of Directors, Dr. Andrea Small-Howard, PhD, MBA. Dr.
Small-Howard comes to GrowBLOX Sciences with an extensive
background in Biotechnology and Biopharmaceutical products.
Dr. Andrea Small-Howard leverages
broad industry knowledge with a focus on managing new product
development that can be commercialized in the U.S. and selected
international markets. She employs an integrated approach to
product commercialization, as her core product development
perspective is augmented with manufacturing, regulatory, supply
chain and corporate alliance experience. Dr. Small-Howard
received her AB from Occidental
College, in addition to receiving both an MBA and a PhD in
Biological Sciences from the University of Southern
California. As a post-doctoral fellow at the Queens Medical
Center in Honolulu, Hawaii, she
lead a project group dedicated to the study of cannabinoids in the
immune system and published two peer-reviewed papers on the
subject. She also screened synthetic cannabinoids at the in
vitro and preclinical levels. Dr. Small-Howard has previously
screened licensing candidates in other biotech disciplines and
developed biopharma products that are currently on the market.
She has also written and filed patents and global regulatory
approvals.
GrowBLOX Sciences, CEO, Craig
Ellins said, "I couldn't be happier to have Andrea on
board. We have been building a business model based on our
proprietary technology and with someone as talented and skilled in
biotechnology as Andrea, we have the research and resources to help
her build on the momentum of our product pipeline. Now that
the FDA has fast tracked clinical trials for certain cannabinoid
medicines, Andrea's experience in FDA product trials will position
our team of scientists to a nutraceutical and pharmaceutical
approved market."
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company
that has developed proprietary indoor growing chambers specifically
designed for medical cannabis cultivation. The GrowBLOX
chamber allows for completely controlled growing conditions,
ensuring the manufacture of a consistent, toxin-free, natural and
medicinal-grade product. The Company believes that the
advantages of a controlled environment over traditional outdoor or
greenhouse growing, will empower the public, nutraceutical and
pharmaceutical industries to embrace cannabis as an effective
treatment for a myriad of serious medical conditions.
http://www.gbsciences.com
Forward-Looking Statements
Except for historical information contained herein, the statements
in this release are forward-looking and made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements are inherently unreliable
and actual results may differ materially. Examples of
forward-looking statements in this news release include statements
regarding the payment of dividends, marketing and distribution
plans, development activities and anticipated operating
results. Factors which could cause actual results to differ
materially from these forward-looking statements include such
factors as the Company's ability to accomplish its business
initiatives, significant fluctuations in marketing expenses and
ability to achieve and expand significant levels of revenues, or
recognize net income, from the sale of its products and services,
as well as the introduction of competing products, or management's
ability to attract and maintain qualified personnel necessary for
the development and commercialization of its planned products, and
other information that may be detailed from time to time in the
Company's filings with the United States Securities and Exchange
Commission. The Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
Contact:
Jonathan Barkman
Riverview Capital Enterprises
+1-866-845-0105
SOURCE GrowBLOX Sciences, Inc.